Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
Journal of Psychiatric Research|February 5, 2017
Improving measurement of attributional style in schizophrenia; A psychometric evaluation of the Ambiguous Intentions Hostility Questionnaire (AIHQ)Benjamin Buck, Colin Iwanski, Kristin M Healey, et al.
The Journal of Clinical Psychiatry|July 7, 2017
Assessment of Suicidal Ideation and Behavior: Report of the International Society for CNS Clinical Trials and Methodology Consensus MeetingPhillip B Chappell, Michelle Stewart, Larry Alphs, et al.
Schizophrenia Bulletin|December 8, 2010
The cultural adaptability of intermediate measures of functional outcome in schizophreniaDawn I Velligan, Maureen Rubin, Megan M Fredrick, et al.
The Journal of Clinical Psychiatry|February 17, 2010
Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitationStephen R Marder, Sebastian Sorsaburu, Eduardo Dunayevich, et al.
The American Journal of Orthopsychiatry|April 26, 2019
Motivational and cognitive correlates of community integration in homeless veterans entering a permanent supported housing programWilliam P Horan, Jonathan K Wynn, Sonya Gabrielian, et al.
Schizophrenia Research|March 13, 2026
Low incidence of extrapyramidal symptoms following treatment with a muscarinic agonist medication for schizophreniaSteven D Targum, Carolyn Watson, Amy Claxton, et al.
The Journal of Clinical Psychiatry|April 2, 2016
Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparisonNina R Schooler, Stephen R Marder, K N R Chengappa, et al.
Psychiatry Research|January 9, 2022
Examining racial differences in community integration between black and white homeless veteransDerek M Novacek, Jonathan K Wynn, Sonya Gabrielian, et al.
Schizophrenia Bulletin|November 12, 2013
The reliability and validity of the MATRICS functional assessment batteryDawn I Velligan, Megan Fredrick, Jim Mintz, et al.
Schizophrenia Bulletin Open|May 22, 2026
A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 2: Perceived Changes in Subjective Quality of Life and Medication SatisfactionPeter Weiden, Cory Saucier, April M Foster, et al.
Pageof 17